Sign in

CIK 0000727510

  • Non-accelerated filer
  • Smaller reporting company

Viskase Holdings, Inc.

Sign in to watch
Ticker
VISK
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
222372868
Phone
+1 630-874-0700
Business address
333 EAST BUTTERFIELD ROAD, SUITE 400, LOMBARD, IL, 60148
Former names
ENZON PHARMACEUTICALS, INC., ENZON PHARMACEUTICALS INC, ENZON PHARMACEUTICALS INC, ENZON PHARMACEUTICAL INC, ENZON INC
  1. 4 Grant or award Director acquired 7,382 shares (grant or award)
  2. 4 Grant or award Director acquired 7,382 shares (grant or award)
  3. 4 Shares withheld for taxes Exec. Vice Pres. HR gave up 1,969 shares (to pay taxes)
  4. 4 Grant or award Senior VP, Finance and CFO acquired 25,000 shares (grant or award)
  5. 3 Insider Initial Statement of Ownership
  6. 4 Open-market sale Director sold 8,702 shares at $10.57 ($91,980)
  7. 4 Shares withheld for taxes EVP, R&D, CSO gave up 9,380 shares (to pay taxes)
  8. 4 Shares withheld for taxes COO and Princ. Exec. Officer gave up 5,951 shares (to pay taxes)
  9. 4 Shares withheld for taxes Exec. Vice Pres. HR gave up 3,767 shares (to pay taxes)
  10. 4 Shares withheld for taxes COO and Princ. Exec. Officer gave up 886 shares (to pay taxes)
  11. 4 Shares withheld for taxes EVP, R&D, CSO gave up 886 shares (to pay taxes)
  12. 4 Shares withheld for taxes Exec. Vice Pres. HR gave up 394 shares (to pay taxes)
  13. 4 Open-market buy Acting VP of Fin & Prin FO bought 2,000 shares at $10.65 ($21,298)
  14. 3 Insider Initial Statement of Ownership
  15. 4 Open-market sale Director sold 10,000 shares at $10.88 ($108,817)
  16. 4 Shares withheld for taxes EVP, R&D, CSO gave up 12,863 shares (to pay taxes)
  17. 5 Insider Annual Insider Trading Report
  18. 5 Insider Annual Insider Trading Report
  19. 4 Shares withheld for taxes Exec. Vice Pres. HR gave up 3,657 shares (to pay taxes)
  20. 5 Insider Annual Insider Trading Report

Page 6 of 28 · 560 filings